Silverarc Capital Management

Silverarc Capital Management as of Dec. 31, 2021

Portfolio Holdings for Silverarc Capital Management

Silverarc Capital Management holds 70 positions in its portfolio as reported in the December 2021 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Spdr Ser Tr S&p Biotech Call Option (XBI) 9.1 $22M 200k 111.96
ImmunoGen 4.6 $11M 1.5M 7.42
Biohaven Pharmaceutical Holding 4.5 $11M 80k 137.81
Intra Cellular Therapies (ITCI) 4.1 $10M 195k 52.34
Merus N V (MRUS) 4.1 $10M 320k 31.80
Veracyte (VCYT) 3.7 $9.1M 221k 41.20
Mirati Therapeutics 3.6 $8.9M 61k 146.68
Bellus Health Com New 3.6 $8.9M 1.1M 8.05
Cogent Biosciences (COGT) 3.0 $7.3M 851k 8.58
Galapagos Nv Spon Adr (GLPG) 2.9 $7.1M 129k 55.13
Cerus Corporation (CERS) 2.9 $7.1M 1.0M 6.81
Horizon Therapeutics Pub L SHS 2.7 $6.6M 62k 107.76
Iteos Therapeutics (ITOS) 2.6 $6.4M 138k 46.56
Apollo Endosurgery 2.5 $6.2M 740k 8.43
Research Alliance Corp Ii Com Cl A 2.2 $5.4M 557k 9.72
Immatics SHS (IMTX) 2.1 $5.3M 391k 13.44
Lucira Health 1.8 $4.4M 515k 8.61
Sierra Oncology Com New 1.7 $4.2M 192k 21.74
Aclaris Therapeutics (ACRS) 1.7 $4.2M 286k 14.54
Amryt Pharma Sponsored Ads 1.5 $3.8M 350k 10.80
Cti Biopharma 1.5 $3.7M 1.5M 2.48
Leap Therapeutics 1.3 $3.3M 1.0M 3.24
Krystal Biotech (KRYS) 1.3 $3.3M 47k 69.96
Morphic Hldg (MORF) 1.3 $3.2M 67k 47.38
Crinetics Pharmaceuticals In (CRNX) 1.3 $3.2M 112k 28.41
United Therapeutics Corporation (UTHR) 1.3 $3.1M 15k 216.07
Xenon Pharmaceuticals (XENE) 1.3 $3.1M 100k 31.24
Halozyme Therapeutics (HALO) 1.2 $2.9M 71k 40.21
Insmed Com Par $.01 (INSM) 1.1 $2.7M 101k 27.24
Seres Therapeutics (MCRB) 1.1 $2.7M 321k 8.33
Cytokinetics Com New (CYTK) 1.1 $2.7M 58k 45.57
Otonomy 1.0 $2.5M 1.2M 2.08
Miragen Therapeutics (VRDN) 1.0 $2.4M 124k 19.77
Viewray (VRAYQ) 1.0 $2.4M 428k 5.51
Aurinia Pharmaceuticals (AUPH) 0.9 $2.3M 100k 22.87
Eyepoint Pharmaceuticals Com New (EYPT) 0.9 $2.2M 182k 12.24
Syndax Pharmaceuticals (SNDX) 0.9 $2.2M 100k 21.89
Stereotaxis Com New (STXS) 0.9 $2.1M 344k 6.20
Jounce Therapeutics 0.8 $2.1M 246k 8.35
Cyclacel Pharmaceuticals 0.7 $1.8M 459k 3.89
Celldex Therapeutics Com New (CLDX) 0.7 $1.7M 45k 38.64
Aslan Pharmaceuticals Ads 0.7 $1.7M 1.5M 1.12
Seagen 0.7 $1.7M 11k 154.59
Bridgebio Pharma (BBIO) 0.7 $1.7M 100k 16.68
Poseida Therapeutics I (PSTX) 0.6 $1.6M 235k 6.81
Deciphera Pharmaceuticals (DCPH) 0.6 $1.6M 161k 9.77
Benitec Biopharma 0.6 $1.5M 588k 2.62
Biogen Idec (BIIB) 0.6 $1.4M 5.7k 239.90
Eloxx Pharmaceuticals 0.6 $1.4M 1.9M 0.71
Helix Acquisition Corp Com Cl A 0.5 $1.3M 132k 9.89
Medicus Sciences Acquisition Cl A Shs 0.5 $1.2M 129k 9.69
Polypid SHS 0.5 $1.2M 216k 5.74
Social Cap Suvretta Hlds Crp Class A Ord Shs 0.5 $1.2M 124k 9.93
Social Cap Suvretta Hld Crpi Class A Ord Shs 0.5 $1.2M 124k 9.90
Social Cap Suvretta Hlds Crp Class A Ord Shs 0.5 $1.2M 124k 9.89
Social Cap Suvretta Hlds Cp Class A Ord Shs 0.5 $1.2M 124k 9.82
Nextcure (NXTC) 0.5 $1.2M 193k 6.00
Point Biopharma Global 0.5 $1.1M 205k 5.60
Vertex Pharmaceuticals Incorporated (VRTX) 0.4 $1.1M 5.0k 219.60
Inhibrx (INBX) 0.4 $1.1M 25k 43.66
Curis Com New Call Option 0.4 $952k 200k 4.76
Compugen Ord (CGEN) 0.4 $944k 220k 4.30
Kura Oncology (KURA) 0.4 $935k 67k 13.99
Innate Pharma S A Sponsored Ads (IPHA) 0.3 $839k 184k 4.56
Vistagen Therapeutics Com New 0.3 $827k 424k 1.95
Evogene SHS (EVGN) 0.2 $481k 293k 1.64
Mereo Biopharma Group Ads (MREO) 0.2 $373k 233k 1.60
Calithera Biosciences 0.1 $146k 220k 0.66
Renovacor *w Exp 99/99/999 0.0 $60k 105k 0.57
Medicus Sciences Acquisition *w Exp 02/12/202 0.0 $36k 50k 0.72